Athanor Capital, LP Abb Vie Inc. Transaction History

Athanor Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $756,775 - $843,091	-7,193 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $357,538 - $393,606	-3,495 Reduced 32.7%	7,193 $778,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $465,634 - $628,655	5,785 Added 117.99%	10,688 $1.15 Million
Q3 2020 Nov 16, 2020	BUY	$85.91 - $100.83 $224,225 - $263,166	2,610 Added 113.82%	4,903 $429,000
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $168,237 - $225,126	2,293 New	2,293 $225,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.